ICLR Latest Headlines

ICON plc Sets July 31, 2026 AGM and Seeks Expanded Capital Authorities

at www.tipranks.com (Fri, 26-Jun 8:28 AM)

Icon Plc Earnings Call Balances Growth and Margin Strain

at www.tipranks.com (Thu, 25-Jun 8:00 PM)

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Icon (ICLR)

at www.tipranks.com (Thu, 25-Jun 9:30 AM)

Jefferies Reaffirms Their Buy Rating on Icon (ICLR)

at www.tipranks.com (Thu, 25-Jun 8:36 AM)

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), Gilead Sciences (GILD) and Icon (ICLR)

at www.tipranks.com (Thu, 25-Jun 8:30 AM)

Charles Rhyee Reiterates Buy on Icon, Lifts Price Target to $197 on Earnings Acceleration and Margin Expansion Confidence

at www.tipranks.com (Wed, 24-Jun 8:05 PM)

Icon reiterates 2026 guidance of $7.85B-$8.15B revenue and $10-$11 EPS amid 1.42x net book-to-bill

at seekingalpha.com (Wed, 24-Jun 1:43 PM)

Biggest stock movers Wednesday: RUN, FDX, ICLR, and more

at seekingalpha.com (Wed, 24-Jun 9:46 AM)

At a glance: stocks gapping up premarket

at seekingalpha.com (Wed, 24-Jun 6:52 AM)

Biggest stock movers Wednesday: FDX, ICLR, and more

at seekingalpha.com (Wed, 24-Jun 5:01 AM)

ICON shares rise as earnings beat and CEO flags strong booking momentum

at seekingalpha.com (Wed, 24-Jun 4:59 AM)

Icon Maintained at Sell as Analyst Keeps $125 Price Target Amid Valuation Concerns After In-Line Q1 2026 Results

at www.tipranks.com (Wed, 24-Jun 4:55 AM)

ICLR Delivers Strong Bookings and Enhanced Backlog Visibility Amid Internal Audit Reforms

Market Chameleon (Thu, 28-May 11:54 AM)

ICLR Investigation Concludes with Minimal Revenue Overstatement—Restatements Announced, Focus Shifts to Forward Growth

Market Chameleon (Wed, 29-Apr 11:47 AM)

ICON Audit Committee Finds Revenue Overstatement Below 2%—Restatement Process Nears Conclusion

Market Chameleon (Wed, 29-Apr 7:58 AM)